Abstract:Patient-derived cancer cells (PDCs) and patient-derived xenografts (PDXs) are often used as tumor models, but have many shortcomings. PDCs not only lack diversity in terms of cell type, spatial organization, and microenvironment but also have adverse effects in stem cell cultures, whereas PDX are expensive with a low transplantation success rate and require a long culture time. In recent years, advances in three-dimensional (3D) organoid culture technology have led to the development of novel physiological systems that model the tissues of origin more precisely than traditional culture methods. Patient-derived cancer organoids bridge the conventional gaps in PDC and PDX models and closely reflect the pathophysiological features of natural tumorigenesis and metastasis, and have led to new patient-specific drug screening techniques, development of individualized treatment regimens, and discovery of prognostic biomarkers and mechanisms of resistance. Synergistic combinations of cancer organoids with other technologies, for example, organ-on-a-chip, 3D bio-printing, and CRISPR-Cas9-mediated homology-independent organoid transgenesis, and with treatments, such as immunotherapy, have been useful in overcoming their limitations and led to the development of more suitable model systems that recapitulate the complex stroma of cancer, inter-organ and intra-organ communications, and potentially multiorgan metastasis. In this review, we discuss various methods for the creation of organ-specific cancer organoids and summarize organ-specific advances and applications, synergistic technologies, and treatments as well as current limitations and future prospects for cancer organoids. Further advances will bring this novel 3D organoid culture technique closer to clinical practice in the future.

Organoid model: A new hope for pancreatic cancer treatment?

[Application and research progress of patient-derived organoids in the multimodality treatment of pancreatic cancer]

Pancreatic Organoids: A Frontier Method for Investigating Pancreatic-Related Diseases

Ultrasound-guided fine-needle aspiration/biopsy-based pancreatic organoids establishment: an alternative model for basic and preclinical research

Advancing cancer research through organoid technology

Organoid Models of Gastrointestinal Neoplasms: Origin, Current Status and Future Applications in Personalized Medicine

Pancreatic Cancer Organoids: An Emerging Platform for Precision Medicine?

Cancer organoids: A platform in basic and translational research

Cancer research revolutionized: unveiling the power of organoids and their therapeutic potential in oncology

Organoids for Cancer Research: Advances and Challenges

Organoid Technology and Clinical Applications in Digestive System Cancer

Organoids: approaches and utility in cancer research

Organoid: Next-Generation Modeling of Cancer Research and Drug Development

Organoids: opportunities and challenges of cancer therapy

A Prospective Advanced Model for Pancreatic Cancer Research

Tumor organoids: synergistic applications, current challenges, and future prospects in cancer therapy

Organoid technology and applications in cancer research

Progress and perspective of organoid technology in breast cancer research

Organoids: Construction and Application in Gastric Cancer

The application of pancreatic cancer organoids for novel drug discovery

Tumor organoids: From inception to future in cancer research